Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants
Background/Aim. Autologous stem cell transplants (ASCTs) improve the rate of overall survival (OS) in patients with hematological malignancies such as multiple myeloma (MM) after induction chemotherapy, aggressive non-Hodgkin's lymphomas (NHL), and relapsed, chemotherapy- sensitive Hodgkin'...
Main Authors: | Todorović-Balint Milena, Bila Jelena, Balint Bela, Jeličić Jelena, Đunić Irena, Antić Darko, Kraguljac-Kurtović Nada, Vujić Dragana, Mihaljević Biljana |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2020-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800160T.pdf |
Similar Items
-
Mobilization potential of patients with lymphomas and multiple myeloma involved in autologous stem cell transplant
by: Stančev Katarina, et al.
Published: (2020-01-01) -
Autologous stem cell transplantation in the treatment of Hodgkin's disease
by: Tarabar Olivera, et al.
Published: (2009-01-01) -
Autologous stem cell transplantation in the treatment of multiple myeloma single center experience
by: Marjanović Slobodan, et al.
Published: (2011-01-01) -
UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01) -
AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IS IT STILL THE RIGHT CHOICE?
by: Patrizia Tosi
Published: (2014-07-01)